European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

BioNTech Cell & Gene Therapies GmbH, Mainz, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

BioNTech Cell & Gene Therapies GmbH
UniCell GmbH

Identification

Ut
District Court of Mainz HRB 42024
EUID
DET2304V.HRB42024

Address

An der Goldgrube 12, 55131 Mainz, Germany

Corporate purpose

Research and development of immune cell-based diagnostics and drugs

Financials

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

5 Jun 2025 via BioNTech SE also 02/06/2025, 06/06/2024, 06/06/2024, 10/05/2023, 10/05/2023, 22/04/2022, 03/05/2021, 27/04/2021, 09/06/2020, 29/01/2020, 02/01/2020, 02/01/2020
Shareholder: BioNTech SE
16 Dec 2024
Managing Director: Sierk Pötting, Ugur Sahin · Authorized signatory (ppa) (4)
Year 2024 in Epobase
4 European patent filings: Chimeric Antigen Receptor-Modified Cells for the Treatment of CLDN6-Expressing Cancers …
20 Dec 2023
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (3)
26 Jul 2023
Patent: Enhancing the Effect of CAR-Engineered T Cells by Means of Nucleic Acid Vaccination
8 Jun 2022
Patent: Agents and Methods for Activation and Targeting of Immune Effector Cells
13 Apr 2022
Patent: Claudin-18.2-Specific Immunoreceptors and T Cell Epitopes
3 Feb 2022
Authorized signatory (ppa): Dirk Schreiber
29 Dec 2021
Patent: Antigen-specific T cell receptors and T cell epitopes
4 Aug 2021
Patent: Antigen Receptors and Uses Thereof
15 Mar 2021
Patent: Antigen-Specific T Cell Receptors and T Cell Epitopes
Year 2020 in Epobase
9 European patent filings: Treatment Involving Immune Effector Cells Genetically Modified to Express Antigen Receptors …
28 Jul 2020
Control: BioNTech SE · Control: BioNTech SE
15 Jul 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
27 May 2020 via BioNTech SE
Shareholding: BioNTech SE
28 Aug 2019
Patent: Antigen-Specific T Cell Receptors and T Cell Epitopes
31 Jul 2019
Patent: Antigen Receptors and Uses Thereof
3 Jun 2019
Authorized signatory (ppa) (3)
2 May 2019
Original document: “Liste der Gesellschafter“
25 Apr 2019
Original document: “Liste der Gesellschafter“
25 Feb 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
21 Feb 2019 via BioNTech AG also 14/02/2019, 14/02/2019, 05/06/2018, 28/02/2018, 07/02/2018, 06/02/2018, 27/01/2017, 26/01/2017, 08/11/2016, 28/10/2016, 01/07/2016, 13/04/2016, 15/06/2015, 05/03/2015, 09/01/2014, 20/03/2013, 27/09/2011, 23/08/2010
Shareholder: BioNTech AG
1 Feb 2019
Wordmark: “UniCell“
16 Jan 2019
Patent: Claudin-6-Specific Immunoreceptors and T Cell Epitopes
12 Sept 2018
Patent: RNA Replicon for Expressing a T Cell Receptor or an Artificial T Cell Receptor
14 Aug 2018
Wordmark: “UniCell“
25 Jun 2018
Wordmark: “UniCell“
15 May 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
5 Jul 2017
Patent: Antigen-Specific T Cell Receptors and T Cell Epitopes
13 Apr 2017
Patent: Antigenrezeptoren und Verwendungen Davon
13 Apr 2017
Patent: Antigenrezeptoren und Verwendungen Davon
15 Mar 2017
Patent: Antigen Receptors and Uses Thereof
Year 2016 in Epobase
4 European patent filings: Antigen Receptors and Uses Thereof …
17 May 2016
Control: BioNTech AG · Control: BioNTech AG
Year 2015 in Epobase
5 European patent filings: Antigen Receptors and Uses Thereof …
30 Jun 2015
Wordmark: “UniCell“
26 May 2015
Capital: €26,453 · Share­holder agreement
11 May 2015
Original document: “Liste der Gesellschafter“
11 May 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
6 Nov 2014
Managing Director: Sierk Poetting · No longer Managing Director (1)
2 Apr 2014
Wordmark: “UniCell“
13 Mar 2014
Address · Name: BioNTech Cell & Gene Therapies GmbH
20 Feb 2014 as UniCell GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
3 Jan 2014 as UniCell GmbH
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
21 Jan 2013 as UniCell GmbH
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
18 Dec 2012 as UniCell GmbH
Managing Director (1)
7 Dec 2012
Managing Director (1)
1 Oct 2012 in Fk
Public funding (€828,180): CI3: Molecularly optimized antigen-specific T cells for individualized immunotherapy of cancer, UniCell project part
26 Sept 2011 as UniCell GmbH
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
16 Mar 2011 as UniCell GmbH
Managing Director: Ugur Sahin
11 Oct 2010 as UniCell GmbH
Managing Director (1)
23 Aug 2010 as UniCell GmbH
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
9 Aug 2010
Wordmark: “UniCell“
4 Aug 2010 as UniCell GmbH
Address
16 Jul 2010
Address
26 May 2010
Wordmark: “UniCell“
2 Feb 2010
Wordmark: “UniCell“
5 Jan 2010 as UniCell GmbH
Control: BioNTech AG · Control: BioNTech AG
28 Dec 2009
Control: BioNTech AG · Control: BioNTech AG
9 Dec 2009 as UniCell GmbH
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
19 Aug 2009 as UniCell GmbH
Control: BioNTech AG · Control: BioNTech AG
4 Aug 2009
Control: BioNTech AG · Control: BioNTech AG · Legal form: AG
27 May 2009 as UniCell GmbH
Reg­is­tra­tion · Managing Director (1) · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
13 May 2009 as UniCell GmbH
Reg­is­tra­tion · Managing Director (1) · Address · Capital: €25,000 · Legal form: GmbH · Name: UniCell GmbH · Corporate Purpose
25 Mar 2009 as UniCell GmbH
Original document: “Liste der Gesellschafter“
25 Mar 2009 as UniCell GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.